Ascendis Pharma A (ASND) Long-Term Debt Repayments (2019 - 2025)
Historic Long-Term Debt Repayments for Ascendis Pharma A (ASND) over the last 6 years, with Q4 2025 value amounting to -$8.0 million.
- Ascendis Pharma A's Long-Term Debt Repayments fell 15263.31% to -$8.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$25.1 million, marking a year-over-year decrease of 10383.92%. This contributed to the annual value of -$24.8 million for FY2025, which is 10432.8% down from last year.
- Ascendis Pharma A's Long-Term Debt Repayments amounted to -$8.0 million in Q4 2025, which was down 15263.31% from -$7.7 million recorded in Q3 2025.
- In the past 5 years, Ascendis Pharma A's Long-Term Debt Repayments registered a high of -$2.4 million during Q1 2021, and its lowest value of -$8.0 million during Q4 2025.
- Its 4-year average for Long-Term Debt Repayments is -$3.9 million, with a median of -$3.0 million in 2024.
- Examining YoY changes over the last 5 years, Ascendis Pharma A's Long-Term Debt Repayments showed a top increase of 655.76% in 2025 and a maximum decrease of 15263.31% in 2025.
- Over the past 4 years, Ascendis Pharma A's Long-Term Debt Repayments (Quarter) stood at -$2.4 million in 2021, then dropped by 24.34% to -$2.9 million in 2023, then dropped by 7.02% to -$3.1 million in 2024, then plummeted by 152.63% to -$8.0 million in 2025.
- Its last three reported values are -$8.0 million in Q4 2025, -$7.7 million for Q3 2025, and -$6.2 million during Q2 2025.